共 182 条
[1]
Wokhlu A(2010)Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect J Am Coll Cardiol 55 2308-2316
[2]
Monahan KH(1969)The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation Am J Cardiol 23 208-216
[3]
Hodge DO(2014)Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis J Neurol 100 550-556
[4]
Asirvatham SJ(2014)Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis Heart 383 955-962
[5]
Friedman PA(2014)Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 111 981-988
[6]
Munger TM(2014)Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis Thromb Haemost 172 267-268
[7]
Bradley DJ(2014)The risk of infection with new oral anticoagulants: a meta-analysis Int J Cardiol 339 b2700-188
[8]
Bluhm CM(2014)Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis Clin Res Cardiol 7 177-1600
[9]
Haroldson JM(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 21 1575-634
[10]
Packer DL(1986)Meta-analysis in clinical trials Control Clin Trials 315 629-680